ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.71
-0.78%
US Tech 100
21,530.80
0.44%
S&P 500
6,114.63
-0.01%
US Dollar vs CAD
1.41885
-0.03%
Bitcoin
97,503.71
0.92%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Dyne Therapeutics Inc (DYN) Share Price

Dyne Therapeutics Inc

Dyne Therapeutics Inc (DYN)

NASDAQ
13.91
-0.14
(-1.00%)
At close: February 14 3:00PM
Delayed by 15 minutes
14.29
0.38
( 2.73% )
After Hours: 5:10PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
14.29
Bid
13.58
Ask
14.50
Volume
984,219
13.76 Day's Range 14.50
13.07 52 Week Range 47.45
Market Cap
1.454B
Previous Close
14.05
Open
14.18
Last Trade
1
@
13.69
Last Trade Time
17:10:08
Financial Volume
US$ 13,759,455
VWAP
13.9801
Average Volume (3m)
1,743,097
Shares Outstanding
101,765,958
Dividend Yield
-
PE Ratio
-6.00
Earnings Per Share (EPS)
-2.32
Revenue
-
Net Profit
-235.94M

About Dyne Therapeutics Inc

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.dyne-tx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DYN. The last closing price for Dyne Therapeutics was US$14.05. Over the last year, Dyne Therapeutics shares have traded in a share price range of US$ 13.07 to US$ 47.45.

Dyne Therapeutics currently has 101,765,958 shares outstanding. The market capitalization of Dyne Therapeutics is US$1.43 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -6.00.

Ask ADVFN Intelligence (AI)

DYN Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
January 10 2025
DYN (-1.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 11 2024
DYN (-1.00%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
December 11 2024
DYN (-1.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
December 10 2024
DYN (-1.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.22-13.446396123616.5116.6413.07134663414.2100283CS
4-0.6-4.0295500335814.8917.17513.07254214414.21962491CS
12-15.285-51.682163989929.57531.3213.07174309718.08153276CS
26-29.6-67.441330599243.8947.4513.07145426625.85705422CS
52-9.31-39.449152542423.647.4513.07135411428.27322287CS
1567.28103.8516405147.0147.454.379637521.77375596CS
260-9.16-39.061833688723.4547.454.363163221.1620744CS

DYN - Frequently Asked Questions (FAQ)

What is the current Dyne Therapeutics share price?
The current share price of Dyne Therapeutics is US$ 14.29
How many Dyne Therapeutics shares are in issue?
Dyne Therapeutics has 101,765,958 shares in issue
What is the market cap of Dyne Therapeutics?
The market capitalisation of Dyne Therapeutics is USD 1.43B
What is the 1 year trading range for Dyne Therapeutics share price?
Dyne Therapeutics has traded in the range of US$ 13.07 to US$ 47.45 during the past year
What is the PE ratio of Dyne Therapeutics?
The price to earnings ratio of Dyne Therapeutics is -6
What is the reporting currency for Dyne Therapeutics?
Dyne Therapeutics reports financial results in USD
What is the latest annual profit for Dyne Therapeutics?
The latest annual profit of Dyne Therapeutics is USD -235.94M
What is the registered address of Dyne Therapeutics?
The registered address for Dyne Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Dyne Therapeutics website address?
The website address for Dyne Therapeutics is www.dyne-tx.com
Which industry sector does Dyne Therapeutics operate in?
Dyne Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CCTGCCSC Technology International Holdings Ltd
US$ 2.69
(46.99%)
917.98k
EDBLEdible Garden AG Inc
US$ 0.2675
(32.75%)
7.56M
GLYCGlycoMimetics Inc
US$ 0.3725
(28.45%)
11.31M
TDTHTrident Digital Tech Holdings Ltd
US$ 0.84
(27.08%)
1.32M
HCTIHealthcare Triangle Inc
US$ 0.55
(14.85%)
6.45M
MGOLMGO Global Inc
US$ 0.505
(-29.63%)
32.83M
INLFINLIF Limited
US$ 12.00
(-26.52%)
422.32k
BHATBlue Hat Interactive Entertainment Technology
US$ 0.05
(-19.35%)
18.54M
TOIIWOncology Institute Inc
US$ 0.0204
(-18.07%)
467
RVYLRYVYL Inc
US$ 1.08
(-14.29%)
41.29k
MGOLMGO Global Inc
US$ 0.505
(-29.63%)
32.83M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.05
(-19.35%)
18.54M
ADTXAditxt Inc
US$ 0.0683
(-2.43%)
16.17M
GLYCGlycoMimetics Inc
US$ 0.3725
(28.45%)
11.31M
EDBLEdible Garden AG Inc
US$ 0.2675
(32.75%)
7.56M

Discussion

View Full Feed
Topgun21 Topgun21 6 minutes ago
$TSSI going to go BALLISITIC $5 BILLION!

This small float will go APE!!!

$TSSI
TSSI
#TSSI

ALL MY OPINION!
Anyone else STOKED they haven’t even PR this. WOWSA!

Thoughts!!
Respectfully,
Maverick
$TSS
TSSI
The GidDy uP Kid The GidDy uP Kid 6 minutes ago
AVGR watcHer...
AVGR
FlyFishingStocks FlyFishingStocks 7 minutes ago
It is an opinion (fundamentally) that is CONFIRMED by technical factors, making a high reward/low risk trade entry. Unlike an opinion, hope or gut feeling that conflicts with technical factors(unconfirmed) = the basis of Confirmation bias.

My reason for debating you on this topic is
AMRN
DTGoody DTGoody 7 minutes ago
This is why I have been loading even though I know this is very risky. Back 6 years ago I bought a very risky sub-penny stock that was trading on the grey sheets or currently what we call the expert market. I almost passed on that stock because it was on the grey sheets, but I decided to take the ri
AFFU
thirdcoast thirdcoast 7 minutes ago
and more from the oval office today........https://www.ttnews.com/articles/trump-energy-council
TGLO
NASDAQ2020 NASDAQ2020 8 minutes ago
Link
ELTP
Major Profits Major Profits 8 minutes ago
"He has said he wants to retire to his race horses this year"
Where did he say that?

TIA
GVSI
WhenMoon WhenMoon 9 minutes ago
Reasons to have fun theorizing M/A talks, at least preliminarily have already begun.
"It is time. We believe now is the right time for merchant acquisition or uplisting finance back. We have been quietly working very hard on this issue, and you should expect to be all about that sometime soon
ELTP
SunshineSmiles SunshineSmiles 10 minutes ago
Maybe the audit from before was done by people associated with old management and now new management is getting it done by a third party not associated with any management from the past. Could be aye?
MONI
toohot toohot 10 minutes ago
No truer words have ever been spoken. Thanks beach---always appreciate you insight.


Still waters run deep. Somethin' is going on. I swear I can feel it in my bones.




BUY $BIEL$
BIEL
nowwhat2 nowwhat2 11 minutes ago
I HATE this company tho !.....
Why ?.......Because weedtrader likes it.

New 52 week high ?.......507 ?........Damn !

https://investorshub.advfn.com/uimage/uploads/2025/2/14/mixyqrace_@_4_5y_UPGAP_SUCKS.jpg
RACE
thirdcoast thirdcoast 12 minutes ago
https://www.ttnews.com/articles/texas-gulflink-oil-port
TGLO
rbtree rbtree 13 minutes ago
Excellent post from stockhouse:

Why I am holding on to my shares
What an incredible week!
I have not sold my precious shares(bought 3 years ago)because there to much news to come very soon!
1.Multi Mineral ressources estimated in coming months
2.Premineral
PWM
Jaguarjacket Jaguarjacket 13 minutes ago
Can you say STEM CELLS! ADIA Does It All!
ADIA
gitreal gitreal 13 minutes ago
Jared's not stupid; he's probably operating legally. He wouldn't risk his whole scheme by getting a NOV from some agency like MSHA or BLM. He's allowed to test and conduct maintenance - that's all he needs to take a few promotional photos and videos.
NBRI
doinit doinit 14 minutes ago
PTHRF,,, Japan needing Pantheon,, https://www.alaskasnewssource.com/video/2025/02/09/gov-mike-dunleavy-talks-trump-alaska-lng-alliance-with-japan/
PTHRF
upper11 upper11 15 minutes ago
I see the two resident clowns are still at it
CRGP
dennisdave dennisdave 15 minutes ago
DennisDave is implying MHRA fucked up the inspections.

I never said anything of the sort Tweety Bird
NWBO
Jaguarjacket Jaguarjacket 17 minutes ago
Hopefully Others Begin to Understand the Health Implications ADIA has to Offer!!
ADIA
CuJunior CuJunior 17 minutes ago
I sent an email to investor relations at Gunnison. I asked them this:
The corporate presentation dated May 21, 2024 says the initial capital for Johnson Camp is 58.9 million.
The current corporate presentation says Stage 2 Construction & Operations are 100% funded by Nuton.
Do
GCUMF
Diversified Diversified 17 minutes ago
The last loan was for less than 200k to pay back taxes. This is being extended. This will also be paid in cash in the future. The cronies are not here anymore. Hans had to take a personal guarantee to keep this alive. Future is bright here. DTC issue was concerning, but it should be updated in OTCma
MEDH
thirdcoast thirdcoast 19 minutes ago
Duffy has started.......Delfin not 1st, but sure to follow
TGLO
Jaguarjacket Jaguarjacket 19 minutes ago
Not my fault you don't understand financial statements
Steady_T Steady_T 19 minutes ago
You do realize that unless you are buying the shares that the company is selling into the market that none of the money you spend on buying shares goes to the company.

Most of your hard earned money is going to other people that have previously bought shares.

The compa
NWBO

Your Recent History

NASDAQ
DYN
Dyne Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads